Matt Outten MBA, ALM, CPC

Matt Outten MBA, ALM, CPC

Chief Executive Officer at QED Therapeutics Oncology and Chief Commercial Officer at BridgeBio

BridgeBio•San Francisco Bay Area, United States

View LinkedIn Profile
Experience25+ Years
LevelLeadership

Executive Overview

I possess a proven track record in large and mid-size pharma and start-up biotechs, developing pre-commercial assets, launching products, driving sales, and gaining preferred coverage. I have worked across a wide range of disease states with a focus in oncology and rare diseases. Further, as an integral member of the executive team, I have conducted investor relations calls, performed due diligence for mergers / acquisitions, and managed co-promotion efforts. My greatest strengths lie in utilizing influence to garner buy-in from internal / external stakeholders, manage commercial strategy, develop long range strategic plans for both pre and post launch, and utilizing available resources to streamline operations, improve sales, and increase product access. I also possess experience in operations management, P&L accountability, Gross-to-Net management, and multimillion-dollar budget management. My reputation as an empowering leader has allowed me to hire, train, manage, develop, evaluate, and retain large teams of top-performing sales, marketing, and regional and national payer team members with full accountability to the organization’s goals. Core Competencies: ✔ Leading Marketing Teams through multiple launches ✔ Driving Sales Teams ✔ New Product and Indication Launch ✔ In-Line / Payer Marketing Strategies ✔ Rebate & Pricing Structuring / Negotiations ✔ Patient Assistance Program Creation ✔ Strategic Alliances / Co-Promotions ✔ Specialty Pharmacy / Distributor Network Formation ✔ Mergers / Acquisitions / Due Diligence ✔ Investor Relations ✔ Gross-to-Net Management ✔ P&L Accountability / Budget Administration ✔ Pipeline Strategy Development ✔ Personnel Recruitment / Management / Development ✔ Pharmacoeconomic Modeling

Career Timeline

Professional employment history
  • BridgeBioCurrent
    Feb 2019–Present· 7 yrs 8 mos
    • Chief Executive Officer, QED Therapeutics, Oncology, Chief Commercial Officer, BridgeBioCurrent
      Feb 2019–Present
  • Jul 2018–Feb 2019· 7 mos
    • Chief Commercial Officer
      Jul 2018–Feb 2019
  • 2013–Jul 2018· 5 yrs 6 mos
    • Vice President of Marketing and Market Access
      2015–Jul 2018
    • Vice President Commercial Operations / Interim CCO
      2014–2014
    • Head of Market Access and Commercial Liaison
      2014–2015
    • Executive Director Market Access / Senior Director Market Access
      2013–2014
  • Jul 2008–Feb 2013· 4 yrs 7 mos
    • Director Managed Markets
      Jun 2010–Feb 2013
    • Associate Director of Reimbursement Strategy and National Accounts
      Jul 2008–Jun 2010
    • US Managed Markets Senior Product Manager - Virology, Oncology, CNS, and New Product Development
      2007–2008
    • US Managed Markets Product Manager Virology and Oncology
      2006–2007
    • US Marketing Product Manager Virology
      2005–2006
    • Virology Biologic Specialty Sales Representative
      2004–2005
  • 2001–2004· 3 yrs
    • Neurohealth Specialty Sales Representative
      2002–2004
    • Pharmaceutical Sales Representative / Field Trainer
      2001–2002

Education

BA

Psychology

Hamilton College

MBA

Management

University of Delaware

Master of Liberal Arts in Extension Studies

Field: International Relations.

Harvard University

Executive Relationship Map

Reports To
Matt Outten MBA, ALM, CPC
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer

Executive Network Preview

BizKonnect has mapped this leadership network including reporting hierarchies, peer connections, and cross-functional relationships.

Verified Contact Information
Email & Direct Dial
Org Chart & Reporting Lines
Buying Committee Insights
AI-Powered Account Mapping

Skills & Expertise

20 of 20 skills
HospitalsPharmacy Benefit ManagementOrganizational LeadershipGastroenterologyProduct LaunchOncologyClinical ResearchMarket Access Strategy Development / ImplementationManaged CareDiabetesHealthcareStrategyMedical DevicesCross-functional Team LeadershipVirologyPharmaceutical SalesNeurologyPharmaceutical IndustryBiotechnologyCardiology